cloxyquin has been researched along with Skin Neoplasms in 1 studies
cloxyquin: has antitubercular activity; structure in first source
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melanoma is one of the most aggressive skin cancers and 5-year survival rate is only 4." | 1.51 | Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARĪ³. ( Chen, S; Dong, Z; Liu, C; Shao, W; Zhang, S; Zhang, W, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Shao, W | 1 |
| Dong, Z | 1 |
| Zhang, S | 1 |
| Liu, C | 1 |
| Chen, S | 1 |
1 other study available for cloxyquin and Skin Neoplasms
| Article | Year |
|---|---|
Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARĪ³.
Topics: Animals; Antineoplastic Agents; Antitubercular Agents; Cell Line, Tumor; Cell Proliferation; Chloroq | 2019 |